People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Biotechnology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. | — | Biotechnology | Series C | $143.0M | $392.9M | 2010 |
| Cocrystal Pharma, Inc. | — | Pharmaceuticals | Series A | $28.9M | $92.9M | 2014 |
| ADRX, Inc. | — | Biotechnology | Series A | $18.1M | $177.3M | 2013 |
| CytomX Therapeutics, LLC | — | Other | Seed | $13.4M | $27.9M | 2014 |
Gary Wilcox at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary Wilcox on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael E. Pfau | 2 | 6 |
| Nancy Stagliano | 2 | 5 |
| Alan Heeger | 2 | 5 |
| Steven D. Rubin | 1 | 9 |
| Matthew Young | 1 | 7 |
| Michael Pfau | 1 | 7 |
| Steven Rubin | 1 | 7 |
| Elaine Jones | 1 | 6 |
| JANE H HSIAO | 1 | 5 |
| Sam Lee | 1 | 5 |
| Roger Kornberg | 1 | 4 |
| Raymond F. Schinazi | 1 | 4 |
| Sean McCarthy | 1 | 3 |
| Jane Hsiao | 1 | 3 |
| Phillip Frost | 1 | 3 |
| Elaine V. Jones | 1 | 3 |
| Frederick W Gluck | 1 | 3 |
| JEFFREY A MECKLER | 1 | 3 |
| John Frank | 1 | 3 |
| Madhavan Balachandran | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.